Kanta Medication List (Phase 3): FHIR Modeling of Control and Annotation Notes
Kanta-medicineringslistan (fas 3): FHIR-modellering av kontroll- och anmärkningsanteckningar Kanta.fi Mål.
Kanta.fi is planning the FHIR modeling of control and annotation notes for the national medication list.
Summary
The Swedish healthcare information system, Kanta.fi, is addressing how to model supplementary 'control' and 'annotation' notes within its medication list (Phase 3) using FHIR. This effort aims to standardize and improve the interoperability of detailed annotation and management information in clinical data.
Key Players
Details
This article reports on a technical development by Kanta.fi, Sweden’s national healthcare IT system, concerning its 'Medication List (Phase 3).' The focus is specifically on how to structure and model supplementary, yet critical, notes—such as 'control' or 'annotation' details—that arise in clinical practice, using the FHIR standard. This goes beyond basic data like drug names and dosages. The goal is to ensure comprehensive medical records and capture detailed contextual information (context) to prevent data loss or misunderstanding during exchange between different systems. By implementing advanced modeling via FHIR, it aims to enable deeper insights into medication usage patterns, ultimately contributing to improved patient care quality and streamlined healthcare processes.
Technology Note
FHIR（Fast Healthcare Interoperability Resources）は医療データ交換の国際標準。このエントリの関連技術: FHIR
Original content copyright by respective publishers